Pfizer (PFE) Q3 2022 Earnings Call Transcript : vimarsana.co

PFE earnings call for the period ending September 30, 2022.

Related Keywords

New York , United States , United Arab Emirates , Israel , Kuwait , Robyn Karnauskas , David Risinger , Andrew Baum , Albert Bourla , Tim Anderson , Chris Stevo , Evan Seigerman , Chris Shibutani , Terence Flynn Morgan Stanley , William Pao , Dave Denton , Angela Hwang , Doug Lankler , Louise Chen Cantor Fitzgerald , Terence Flynn , Andrew Baum Citi , Geoff Meacham , Steve Scala Cowen , Steve Scala , America Merrill Lynch , Chris Schott Jpmorgan , Aamir Malik , Robyn Karnauskas Truist , Mikael Dolsten , Louise Chen , Chris Schott , Chris Shibutani Goldman Sachs , Colin Bristow , Mohit Bansal , Morgan Stanley , Accor , Goldman Sachs , Geoff Meacham Bank , Brian Tsang Wolfe Research Analyst , Worldwide Research , Pfizer , Global Fund , European Union , Wolfe Research , Company Analyst , Wells Fargo , Biohaven Pharmaceuticals , Drug Administration , Data Monitoring Committee , European Medicines Agency , Vice President , Chief Investor Relations , Analyst Day , New York City , Investor Relations , Risk Factors , Forward Looking Information , Factors That May Affect Future , Chief Executive , Global Blood Therapeutics , Umer Raffat , Global Blood , Chief Development , Fargo Securities , Truist Securities , Executive Vice President , Wells Fargo Securities ,